News for Profound Medical Corp. (PROF)

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Profound Medical Corp. (”œProfound” or the ”œ

TORONTO, April 17, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF; TSX:PRN) (”œProfound” or the ”œCompany”), a commercial-stage medical device co

**media[595471]**

PR NewswireNEW YORK, April 14, 2025 NEW YORK, April 14, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Profound Medic

NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Profound Medical Corp. (”œProfound” or the ”

PR NewswireLOS ANGELES, April 3, 2025 LOS ANGELES, April 3, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announ

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Profound Medical Corp. (”œProfound” or the ”œ

TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (PROF; TSX:PRN) (”œProfound” or the ”œCompany”), a commercial-stage medical device co

**media[575889]**

[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Profound M

PR NewswireNEW YORK, March 17, 2025 NEW YORK, March 17, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Profound Medi

Law Offices of Howard G. Smith announces an investigation on behalf of Profound Medical Corp. (”œProfound” or the ”œCompany”) (NASDAQ: [url="]PROF[/url])

[url="]The Law Offices of Frank R. Cruz[/url] announces an investigation of Profound Medical Corp. (”œProfound” or the ”œCompany”) (NASDAQ: [url="]PROF[/

Revenue: $4.2 million for Q4 2024, including $2.7 million from current revenue and $1.5 million from one-time sale of capital equipment.Revenue Growth: 108% in

Mar 06, 2025 / 09:30PM GMTOperator Thank you for standing by and welcome to the Profound Medical fourth-quarter and full-year 2024 financial results conference

Profound Medical (PROF) delivered earnings and revenue surprises of 33.33% and 0.55%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Profound Medical Corp (TSX:PRN) is set to release its Q4 2024 earnings on March 6, 2025. The consensus estimate for Q4 2024 revenue is $6.15 million, and the ea

**media[540376]**

On December 31, 2024, GAGNON SECURITIES LLC (Trades, Portfolio) made a notable addition to its portfolio by acquiring 1,879,496 shares of Profound Medical Corp